- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07619625
Care Bundle to Limit External Ventricular Drain Associated iNfections (CLEAN-EVD)
26. maj 2026 opdateret af: Centre Hospitalier Universitaire de Nice
The aim of our study is to reduce the incidence of External ventricular drain (EVD)-related infections by implementing a bundle of measures including updated care protocoles and training of residents, nurses and nurses assistants.
At Nice University Hospital, we are conducting a retrospective study showing a 22% infection rate associated with EVD.
The identified pathogens are mainly transmitted by manual contact.
Additionnally, high turnover among paramedical staff and sometimes rapid training may contribute to infection ocurrence.
We hypothesize that a significant proportion of patients with EVD develop nosocomial ventriculitis, primarily due to modificable risk factors such as catheter handling and breaches in aseptic technique.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Undersøgelsestype
Observationel
Tilmelding (Anslået)
248
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Julie Borovik
- Telefonnummer: 06 98 86 83 50
- E-mail: borovik.j@chu-nice.fr
Undersøgelse Kontakt Backup
- Navn: Pauline Duchemin
- Telefonnummer: 0602650248
- E-mail: duchemin.p@chu-nice.fr
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
The study population consists of adult patients admitted to the general intensive care and intermediate care units of Nice University Hospital who underwent EVD placement on site.
Beskrivelse
Inclusion Criteria:
- Age ≥ 18 years.
- Hospitalized in a general intensive care unit or intermediate care unit at Nice University Hospital.
- Having undergone EVD placement within the institution.
Exclusion Criteria:
- EVD placed outside the institution with no possibility of follow-up.
- Patient under immediate therapeutic limitation.
- Pre-existing neuromeningeal infection.
- Expression by the patient or by the trusted person of opposition to the processing of the patient's medical data.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
EVD-associated infection cohort in CIU and step-down care
|
Preventive measures are structured around several key areas : updating the EVD insertion protocol and the EVD care protocol, optimizing dressing changes and scalp cleansing ; ; creation of reminder signage displayed outside the rooms of patients with an EVD outlining key hygiene rules ; implementation of theoretical teaching and simulation sessions for residents and nurses, covering EVD management, infectious complications, their treatment, and prevention ; assessment through a questionnaire on EVD management before implementation of preventive measures and after.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Occurrence of an infection related to EVDs between the day of insertion and up to 30 daysafterward.
Tidsramme: From the inclusion up to 30 days
|
Number of infections according to the 2017.
Altération de la biochimie du LCR.
Clinical deterioration of the patient
|
From the inclusion up to 30 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Occurrence of a contamination related to EVDs
Tidsramme: From the inclusion up to 30 days.
|
Number of contamination according to : CSF with a single positive culture or a direct examination with Gram staining showing a microorganism, without any alteration in CSF biochemistry and without clinical deterioration.
CSF contamination corresponds to the detection of microorganisms in a CSF sample that do not originate from the site being studied (CSF).
|
From the inclusion up to 30 days.
|
|
Occurrence of a colonisation related to EVDs
Tidsramme: From the inclusion up to 30 days.
|
Number of colonisation according to CSF with multiple positive cultures or multiple direct examinations with Gram staining showing a microorganism, without any alteration in CSF biochemistry and without clinical deterioration.
CSF colonization corresponds to the presence of microorganisms in the CSF without any associated clinical manifestations.
|
From the inclusion up to 30 days.
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. juni 2026
Primær færdiggørelse (Anslået)
1. oktober 2028
Studieafslutning (Anslået)
1. december 2028
Datoer for studieregistrering
Først indsendt
26. maj 2026
Først indsendt, der opfyldte QC-kriterier
26. maj 2026
Først opslået (Faktiske)
2. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
2. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
26. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 26Anesthesie-Réa
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Health Care Associated Infection
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of Rome Tor Vergata; Fondazione IRCCS Ca' Granda, Ospedale Maggiore... og andre samarbejdspartnereRekrutteringHealth Care Associated InfectionItalien
-
University of Colorado, DenverUniversity of IowaAfsluttetHealth Care Associated Infection | HåndhygiejneForenede Stater
-
Okan UniversityAfsluttetHud | Health Care Associated InfectionKalkun
-
Gehad Salah El-Den Mahmoud MohammadAfsluttet
-
VA Office of Research and DevelopmentAfsluttetHealth Care Associated Infection | Håndhygiejne | OverholdelseForenede Stater
-
Randy LoftusRDB Bioinformatics, LLCAfsluttetStaphylococcus Aureus | Sundhedsplejerske Patientoverførsel | Health Care Associated InfectionForenede Stater
-
Akdeniz UniversityAfsluttetIntensivafdeling | Patientcentreret pleje | Health Care Associated Infection | KompetenceKalkun
-
Uludag UniversityAfsluttetHealth Care Associated Infection | Træningsgruppe, Følsomhed | HåndKalkun
-
Jianfeng XieRekrutteringCLABSI - Central Line Associated Bloodstream InfectionKina
-
Centre Hospitalier Universitaire de BesanconUkendtAntibiotika-resistent stamme | Health Care Associated Infection | Overførsel af infektionFrankrig